Nucala 100 MG/ML auto-injectorml
Ended Awarded
- Contract number
- SPE2DB25FZK68
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,143
Award facts
- Contract value 100% obligated
- $15,143.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $15,143.20 by the Defense Logistics Agency for the supply of Nucala 100 mg/ml auto-injectors. The contract, awarded on July 30, 2025, with an ultimate completion date of July 31, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, which is valued at $499,999,999 and extends through November 2026, enabling the agency to procure a comprehensive range of pharmaceutical products to support medical supply needs across Department of Defense healthcare facilities.
The Defense Logistics Agency's SPE2DB program provides a centralized vehicle for the acquisition of branded and generic prescription drugs, biologics, over-the-counter medications, and medical consumables needed by military health facilities nationwide. As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group leverages its woman-owned small business status and established track record to deliver specialized pharmaceutical products including auto-injectors, vaccines, oncology treatments, and other prescription medications directly to Department of Defense healthcare sites. The Nucala auto-injector delivery fulfills the immediate medical supply requirements of the Defense Logistics Agency's supported facilities.
Quick answers
Who was awarded contract SPE2DB25FZK68?
SPE2DB25FZK68 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 30, 2025.
How much is contract SPE2DB25FZK68 worth?
The government has obligated $15,143 on SPE2DB25FZK68.
Is contract SPE2DB25FZK68 an order under another contract?
Yes. SPE2DB25FZK68 is a delivery order under SPE2DB20D9329, an indefinite delivery contract.
Was contract SPE2DB25FZK68 competed?
The extent of competition for SPE2DB25FZK68 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award